{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T07:17:55Z","timestamp":1760426275816,"version":"3.41.2"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disorder characterized by asymmetric hypertrophy of the ventricles and the ventricular septum, leading to subsequent left ventricular outflow tract (LVOT) obstruction and diastolic dysfunction. Typically, patients with HCM experience sinus tachycardia and sinus arrest relatively infrequently. In addition, the concurrent occurrence of HCM with non-surgically induced (ablation or myectomy) bradyarrhythmia and idiopathic pericardial effusion in adult patients has not been previously reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case summary<\/jats:title><jats:p>In this report, we present two elderly female patients with HCM who exhibited sinus bradycardia and sinus arrest, one of whom also presented with moderate pericardial effusion, they all presented with chest tightness. To manage the complex comorbidities, we opted for dual-chamber pacemaker implantation. Subsequent examinations and follow-up revealed that pacing significantly reduced LVOT obstruction and corrected heart rhythm. Additionally, there was no significant progression of pericardial effusion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The primary strategies for alleviating LVOT obstruction involve altering the structure of the septum, including septal myectomy (SME), alcohol septal ablation (ASA), and septal radiofrequency ablation. Meanwhile, a dual-chamber pacemaker can treat HCM by changing the sequence of myocardial contraction. Although pacemakers have been considered an inferior alternative due to their relatively large residual obstruction, their benefits may be significantly underestimated. This report underscores the additional efficacy of dual-chamber pacemakers in managing HCM, particularly in patients complicated by sinus node dysfunction and idiopathic pericardial effusion.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2025.1518000","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T07:03:23Z","timestamp":1740639803000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Dual-chamber pacemaker for hypertrophic cardiomyopathy with bradyarrhythmia and idiopathic pericardial effusion: a report of two cases and literature review"],"prefix":"10.3389","volume":"12","author":[{"given":"Chang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuqing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1161\/01.CIR.72.2.310","article-title":"Diastolic abnormalities in patients with hypertrophic cardiomyopathy: relation to magnitude of left ventricular hypertrophy","volume":"72","author":"Spirito","year":"1985","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/jcdd911037","article-title":"Characteristics of primary bradyarrhythmia in hypertrophic cardiomyopathy: a 10-year, single-center analysis","volume":"9","author":"Zhang","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0300-8932(10)70210-4","article-title":"Trastornos graves de la conducci\u00f3n cardiaca e implante de marcapasos en pacientes con miocardiopat\u00eda hipertr\u00f3fica","volume":"63","author":"Barriales-Villa","year":"2010","journal-title":"Rev Esp Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1093\/eurheartj\/eht006","article-title":"Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure","volume":"34","author":"Fr\u00f6hlich","year":"2013","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10554-021-02424-8","article-title":"Idiopathic pericardial effusion in patients with hypertrophic cardiomyopathy","volume":"38","author":"Puwanant","year":"2022","journal-title":"Int J Cardiovasc Imaging"},{"key":"B6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s40256-023-00599-0","article-title":"Aficamten: a breakthrough therapy for symptomatic obstructive hypertrophic cardiomyopathy","volume":"23","author":"Sebastian","year":"2023","journal-title":"Am J Cardiovasc Drugs"},{"key":"B7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1253\/circj.CJ-20-1191","article-title":"Relationship between procedural right bundle branch block and 1-year outcome after alcohol septal ablation for hypertrophic obstructive cardiomyopathy- a retrospective study","volume":"85","author":"Matsuda","year":"2021","journal-title":"Circ J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.21037\/jtd-20-2779","article-title":"Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation","volume":"13","author":"Yang","year":"2021","journal-title":"J Thorac Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.14740\/cr512w","article-title":"Treating a structural heart disease using a non-structural approach: role of cardiac pacing in hypertrophic cardiomyopathy","volume":"8","author":"Albano","year":"2017","journal-title":"Cardiol Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/jamacardio.2022.0259","article-title":"Percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy","volume":"7","author":"Zhou","year":"2022","journal-title":"JAMA cardiology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.jacbts.2020.08.006","article-title":"Septal reduction using transvenous intramyocardial cerclage radiofrequency ablation","volume":"5","author":"Shin","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.acvd.2013.04.003","article-title":"Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy","volume":"106","author":"Lucon","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1136\/hrt.2008.158915","article-title":"Late benefits of dual-chamber pacing in obstructive hypertrophic cardiomyopathy: a 10-year follow-up study","volume":"96","author":"Galve","year":"2010","journal-title":"Heart"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.hrthm.2023.05.021","article-title":"Optimizing diastolic filling by pacing in nonobstructive hypertrophic cardiomyopathy","volume":"20","author":"Subramanian","year":"2023","journal-title":"Heart Rhythm"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/ejhf.1722","article-title":"Biventricular pacemaker therapy improves exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy via augmented diastolic filling on exercise","volume":"22","author":"Ahmed","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","article-title":"2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"42","author":"Glikson","year":"2021","journal-title":"Eur Heart J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines","volume":"149","author":"Ommen","year":"2024","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jacc.2022.07.019","article-title":"Randomized trial of left bundle branch vs. biventricular pacing for cardiac resynchronization therapy","volume":"80","author":"Wang","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jacc.2019.04.026","article-title":"His corrective pacing or biventricular pacing for cardiac resynchronization in heart failure","volume":"74","author":"Upadhyay","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/pace.14336","article-title":"Is his-optimized superior to conventional cardiac resynchronization therapy in improving heart failure? Results from a propensity-matched study results from a propensity-matched study","volume":"44","author":"Senes","year":"2021","journal-title":"Pacing Clin Electrophysiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/S0735-1097(96)00586-4","article-title":"Long-term effect of right ventricular pacing on myocardial perfusion and function","volume":"29","author":"Tse","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1161\/01.CIR.0000150336.86033.8D","article-title":"Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing","volume":"110","author":"Thambo","year":"2004","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0735-1097(99)00173-4","article-title":"Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy","volume":"34","author":"Ommen","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"B25","first-page":"333","article-title":"Transcoronary ablation of septal hypertrophy versus dual-chamber cardiac pacing for the treatment of aged patients with hypertrophic obstructive cardiomyopathy","volume":"35","author":"Gao","year":"2007","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"B26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0735-1097(96)00473-1","article-title":"Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial","volume":"29","author":"Nishimura","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.echo.2007.11.014","article-title":"Clinical and echocardiographic variables fail to predict response to dual-chamber pacing for hypertrophic cardiomyopathy","volume":"21","author":"Binder","year":"2008","journal-title":"J A Soc Echocardiogr"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1518000\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T07:03:28Z","timestamp":1740639808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1518000\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":27,"alternative-id":["10.3389\/fcvm.2025.1518000"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1518000","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"article-number":"1518000"}}